This inventor holds 3 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 1989-1992.
Company Filing History:
Years Active: 1989-1992
Title: Michele Yarnall: Innovator in Bacterial Fc Receptors
Introduction
Michele Yarnall is a prominent inventor based in Pullman, WA (US). She has made significant contributions to the field of immunology, particularly in the study of bacterial Fc receptors. With a total of 3 patents to her name, Yarnall's work has advanced our understanding of how these receptors interact with human antibodies.
Latest Patents
Yarnall's latest patents include groundbreaking research on Type II bacterial Fc receptors. This invention describes a type II, proteinaceous, antigenic factor derived from Group A streptococci, which serves as a receptor for the Fc region of human Ig G3. The receptor exhibits a major diffuse protein band on polyacrylamide gel electrophoresis and has a molecular weight of approximately 38,000 daltons. Another patent focuses on bacterial Fc receptors, reiterating the importance of this antigenic factor in immunological research.
Career Highlights
Michele Yarnall is affiliated with the University of Florida Research Foundation, Incorporated, where she continues her innovative work. Her research has not only contributed to academic knowledge but has also paved the way for potential therapeutic applications in treating bacterial infections.
Collaborations
Yarnall collaborates with esteemed colleagues, including Michael D. Boyle, enhancing the impact of her research through shared expertise and insights.
Conclusion
Michele Yarnall's contributions to the field of immunology through her patents on bacterial Fc receptors highlight her role as a leading inventor. Her work continues to influence research and potential treatments in the medical field.